CJC-1295 (5mg) + Ipamorelin (5mg) is a defined 10mg peptide blend formulated for controlled laboratory research. The preparation contains equal quantities of CJC-1295 and Ipamorelin in a single lyophilized formulation, providing researchers with a convenient material for experimental studies involving peptide signaling, growth hormone-related pathways, endocrine communication, and associated cellular mechanisms.
CJC-1295 is a synthetic peptide associated with Growth Hormone-Releasing Hormone (GHRH) signaling, while Ipamorelin is investigated as a selective growth hormone secretagogue. Because the two peptides are associated with different mechanisms within growth hormone-related signaling, researchers may evaluate their combined activity in appropriate experimental models.
The product is supplied as a lyophilized powder and is intended exclusively for qualified laboratory researchers. Experimental preparation, handling, storage, and application should be performed according to validated laboratory procedures and applicable documentation.
Product Specifications
- Product: CJC-1295 + Ipamorelin peptide blend
- CJC-1295: 5mg
- Ipamorelin: 5mg
- Total peptide content: 10mg
- Ratio: 1:1
- Form: Lyophilized powder
- Research category: Peptide research material
- Bacteriostatic water: Sold separately
- Intended application: In vitro laboratory research only
The defined 5mg + 5mg composition provides a clearly specified quantity of each peptide within a single research formulation.
CJC-1295 and Ipamorelin Research
CJC-1295 and Ipamorelin are investigated in experimental systems involving growth hormone-associated signaling and endocrine pathways. Researchers may use these peptide materials to examine cellular responses to peptide-mediated signaling under controlled laboratory conditions.
CJC-1295 is associated with GHRH-related signaling, whereas Ipamorelin is studied as a growth hormone secretagogue. Investigating these compounds together can provide an experimental model for examining different components of growth hormone-related signaling pathways.
Research findings should always be interpreted according to the specific experimental model, concentration, assay methodology, and biological system being studied.
Growth Hormone Signaling Research
Growth hormone signaling involves a complex network of hormonal communication, receptors, intracellular pathways, and downstream cellular responses. Research involving CJC-1295 and Ipamorelin may help characterize selected aspects of these pathways.
Potential laboratory research areas include:
- Growth hormone-associated signaling pathways
- GHRH-related signaling mechanisms
- Secretagogue-mediated signaling
- Peptide-receptor interactions
- Cellular signal transduction
- Endocrine communication
- Downstream cellular responses
- Experimental pathway characterization
These research applications describe areas of scientific investigation and should not be interpreted as evidence that the product has an established therapeutic effect.
Cellular Metabolism Research
Growth hormone-related pathways can be investigated in experimental models involving cellular metabolism and protein-related processes. Researchers may examine changes in cellular markers, signaling activity, metabolic responses, or other measurable endpoints following exposure to experimental peptide preparations.
The CJC-1295 + Ipamorelin blend may therefore be relevant to laboratory investigations focused on the relationship between peptide signaling and cellular processes.
The appropriate experimental conditions, assay design, and analytical endpoints should be determined by qualified researchers according to their validated protocols.
Endocrine Communication Studies
Endocrine systems rely on complex interactions between hormones, receptors, tissues, and intracellular signaling pathways. CJC-1295 and Ipamorelin are research compounds associated with growth hormone-related endocrine signaling.
Laboratory studies may investigate how peptide-mediated signals interact with endocrine pathway components or produce measurable cellular responses. Such experiments can contribute to the characterization of hormone-associated signaling mechanisms without implying clinical or therapeutic efficacy.
CJC-1295 No DAC and Ipamorelin
Researchers may encounter CJC-1295 products described as either DAC or no-DAC formulations. These terms refer to differences in the peptide formulation and associated structural characteristics.
When evaluating a CJC-1295 + Ipamorelin research material, researchers should verify the exact CJC-1295 form rather than assuming that every product described as CJC-1295 contains the same formulation.
For experimental consistency, laboratories should review available product specifications and analytical documentation, including batch-specific information where available.
Storage and Handling
Store the unopened lyophilized material in an appropriate cool, dry environment according to the applicable product documentation.
Following reconstitution, the prepared material should be maintained under appropriate laboratory conditions. A refrigerated range of 2°C–8°C may be applicable to prepared material, subject to the specific stability information and laboratory protocol being used.
Researchers should avoid assuming that a particular storage condition guarantees stability for every preparation. Stability can depend on factors including formulation, concentration, diluent, container, handling procedures, temperature, and storage duration.
All handling should be performed by appropriately qualified personnel using suitable laboratory practices.
Research Applications
The CJC-1295 + Ipamorelin blend may be relevant to experimental research involving:
- Growth hormone signaling
- GHRH-associated pathways
- Growth hormone secretagogue research
- Endocrine signaling models
- Cellular signal transduction
- Cellular metabolism
- Protein synthesis-related research
- Peptide-receptor interaction studies
- Experimental pharmacology
- Molecular and cellular research
- Hormone-associated pathway characterization
The actual suitability of the material depends on the research model and objectives established by the laboratory.
Why Choose a 5mg + 5mg Peptide Blend?
The 10mg formulation provides a defined equal composition of CJC-1295 and Ipamorelin in one lyophilized preparation. This format may be useful for researchers who specifically require both peptide materials within the same experimental workflow.
Key product characteristics include:
- Defined 1:1 peptide composition
- 5mg CJC-1295 per vial
- 5mg Ipamorelin per vial
- 10mg total peptide content
- Single-vial research formulation
- Lyophilized presentation
- Clearly specified research material
- Suitable for controlled laboratory investigation
Researchers should independently determine whether a blended formulation is appropriate for their specific experimental requirements.
Frequently Asked Questions
What is CJC-1295 + Ipamorelin?
CJC-1295 + Ipamorelin is a combined research peptide formulation containing 5mg of CJC-1295 and 5mg of Ipamorelin for a total of 10mg of peptide material.
How much CJC-1295 is included?
Each vial contains 5mg of CJC-1295.
How much Ipamorelin is included?
Each vial contains 5mg of Ipamorelin.
What is the ratio of CJC-1295 to Ipamorelin?
The formulation contains an equal 1:1 quantity, with 5mg of each peptide.
What is CJC-1295 studied for?
CJC-1295 is investigated in experimental models involving GHRH-associated signaling and growth hormone-related pathways.
What is Ipamorelin studied for?
Ipamorelin is investigated as a selective growth hormone secretagogue in laboratory models involving peptide and endocrine signaling.
Is this CJC-1295 DAC or no DAC?
The exact CJC-1295 formulation should be verified from the product specification and analytical documentation. Researchers should not assume that a CJC-1295 product is DAC or no-DAC based solely on the product name.
Is the peptide blend supplied in liquid form?
No. The product is supplied as a lyophilized powder.
Is bacteriostatic water included?
No. Bacteriostatic water is sold separately.
What is the product intended for?
The product is intended strictly for controlled in vitro laboratory research by qualified professionals.
Is CJC-1295 + Ipamorelin approved for human use?
No. This research material is not intended for human or veterinary use, consumption, self-administration, or clinical application.
Can this product be used for bodybuilding or performance enhancement?
No. The product is designated for laboratory research only and is not marketed or intended as a bodybuilding, athletic-performance, recovery, or human-use product.
Important Research-Use Disclaimer
This product is supplied strictly for laboratory research purposes. It has not been evaluated or approved by the FDA or other regulatory authorities for human or veterinary use. It is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.
This material must not be used in humans, animals, food, pharmaceuticals, cosmetics, clinical applications, or diagnostic procedures. Research involving this material should be conducted only by appropriately qualified personnel using established laboratory procedures and in accordance with applicable laws, regulations, institutional requirements, and safety practices.
Reviews
There are no reviews yet.